Image Source: Pfizer Inc – March 2019 IR Presentation
By Callum Turcan
Pfizer Inc (PFE) yields ~3.9% as of this writing and due to the strength of its free cash flow profile, we view the big pharmaceutical company’s dividend as well-protected. Our fair value estimate sits at $43 per share of PFE, comfortably above where PFE is trading at as of this writing, a valuation that’s derived through our discounted cash flow analysis. By forecasting Pfizer’s future financial performance to obtain its expected free cash flows into perpetuity, investors can get a glimpse